Gaochen Lan

Dr. Gaochen Lan


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2025 in Frontiers in Public Health
Verified
Journal Article
Open access
PDF file
YLYunyan Lu
Yunyan Lu
YMYu Mao
Yu Mao
WLWeiguo Liu
Weiguo Liu
TLTian Lan
Tian Lan
GLGaochen Lan
Gaochen Lan
Background: To evaluate the spatiotemporal variation in ischemic stroke attributed to particulate matter 2.5 (PM2.5) on global, regional, and national scales from 1990 to 2021 is essential for mitigating air pollution and controlling ischemic stroke.Methods: The death and disability-adjusted life years (DALYs) were extracted from the Global Burden and Disease Study (GBD) 2021. We utilized joinpoint regression and decomposition analysis to assess PM2.5 exposure and pinpoint high-risk areas.Results: In 2021, PM2.5 caused approximately 0.90 million mortality and 18.29 million DALYs due to ischemic stroke worldwide. The age-standardized rates (ASRs) of ischemic stroke linked to ambient PM2.5 slightly declined, while those associated with household PM2.5 significantly decreased over the past 32 years. The burden of ischemic stroke attributable to ambient and household PM2.5 exhibited considerable heterogeneity across 204 countries. Household PM2.5 significantly affected ischemic stroke burdens in low Socio-demographic indices (SDI) regions, whereas ambient PM2.5 had a greater impact in middle, high-middle, and high SDI regions. In the regions with an SDI below 0.7, including Southern Sub-Saharan Africa and East, South, and Southeast Asia, there was a positive correlation between SDI and ASRs linked with ambient PM2.5. Notably, in the 65–95 age group, the age-specific rates associated with ambient PM2.5 showed a substantial decline among females, while the rates for males remained relatively stable.Conclusion: Our results presented that PM2.5 significantly affects global ischemic stroke burden, particularly among the male population and in low SDI regions. It highlighted the urgency of integrating PM2.5 reduction strategies with ischemic stroke prevention programs.

6 January 2024 in BMC Public Health
Verified
Journal Article
Open access
PDF file
QGQiusheng Guo
Qiusheng Guo
YLYunyan Lu
Yunyan Lu
WLWeiguo Liu
Weiguo Liu
GLGaochen Lan
Gaochen Lan
TLTian Lan
Tian Lan
Objective: Tobacco has been identified as a significant contributory element to the development of breast cancer. Our objective was to evaluate the spatiotemporal trends of tobacco-related breast cancer at the global, regional, and national scales during 1990–2019. Methods: We extracted data on mortality, disability adjusted of life years (DALYs), age-standardized mortality rate (ASMR), and age-standardized DALYs rate (ASDR) from the Global Burden of Disease (GBD) study 2019. Estimated annual percentage change (EAPC) was computed to assess the temporal change in ASDR and ASMR. Results: In 2019, the deaths and DALYs attributed to tobacco-related breast cancer were estimated to be 35,439 (95% UI: 22,179–48,119) and 1,060,590 (95% UI: 622,550–1,462,580), respectively. These figures accounted for 5.1% and 5.2% of the total burden of breast cancer. ASMR and ASDR increased in low SDI regions, remained stable in low-middle and middle SDI regions and declined in high and high-middle SDI regions. The burden of breast cancer attributable to tobacco varied notably among regions and nations. Oceania, Southern Latin America, and Central Europe were the GBD regions with the highest number of ASMR and DALYs. There was a positive relationship between age-standardized rate and SDI value in 2019 across 204 nations or territories. A negative association was observed between the EAPC in ASMR or ASDR and the human development index (HDI) in 2019 (R = -0.55, p < 0.01 for ASMR; R = -0.56, p < 0.01 for ASDR). Conclusion: Tobacco is one important and modifiable risk factor for breast cancer. The heterogeneity in both the spatial and temporal distribution can be attributed to factors such as aging, population growth, and SDI. These findings substantiate the necessity of expediting the enforcement of tobacco-free legislation in order to safeguard populations from the detrimental effects of tobacco.

14 July 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
QGQiusheng Guo
Qiusheng Guo
XLXianmei Lv
Xianmei Lv
ZZZengpai Zheng
Zengpai Zheng
GLGaochen Lan
Gaochen Lan
Melanoma is the most common malignant tumor, with a large patient population. Metastatic melanoma typically occurs in sites such as lymph nodes, skin, lungs, liver, brain, and bones. This metastatic spread often indicates advanced disease, with significantly decreased treatment efficacy and patient survival rates. Accurately predicting the early death (six months) rates of patients with metastatic melanoma to guide the selection of optimal treatment strategies is an urgent clinical issue in need of resolution. Patient demographic and clinical information for this study was extracted from the SEER database. Univariate and multivariate logistic regression analyses were used to screen for independent risk factors. Operating Characteristic curve (ROC) and calibration curve were used to validate the accuracy of the model. Decision curve analysis (DCA) was used to assess the model’s benefit to patients. Finally, Kaplan-Meier survival curves were plotted to show differences in patient survival across risk groups. A total of 1109 patients were included in the study and randomly allocated to a training cohort (n = 777) and a validation cohort (n = 332). Logistic regression analysis identified six variables as independent factors influencing short-term survival in patients with metastatic melanoma, which were used to construct a nomogram. The Receiver Operating Characteristic (ROC) curve demonstrated good performance of the nomogram in both the training cohort (AUC = 0.755) and the validation cohort (AUC = 0.694). The calibration curve showed good fit. Decision curve analysis (DCA) indicated that patients can derive significant benefit from using this nomogram. We have successfully developed and well validated a nomogram that accurately predicts early death (6 months) in patients with transformational melanoma. This can assist clinicians in choosing better clinical strategies for their patients.

1 January 2025 in Mediators of Inflammation
Verified
Journal Article
Open access
LLLang Li
Lang Li
YZYing Zhu
Ying Zhu
CZChenchong Zhao
Chenchong Zhao
YTYinuo Tangwu
Yinuo Tangwu
LHLvyuan He
Lvyuan He
GLGaochen Lan
Gaochen Lan
Background: Lung cancer oncogenesis involves interactions between immune cells and inflammatory cytokines. However, their causal relationships and mediating mechanism remain unclear. Methods: Using a mediating Mendelian randomization (MR) approach, we analyzed genome‐wide association study (GWAS) data for 731 immune‐cellular phenotypes, 41 cytokines, and eight related lung cancer phenotypes. Results: BAFF-R expression in IgD + CD24 + B cells was positively associated with lung adenocarcinoma (LUAD) risk (odds ratio [OR], 1.0168 [95% confidence interval [CI], 1.0006–1.0332]), mediated by macrophage migration inhibition factor (MIF) with a mediation proportion of 14.2% (95% CI, 0.00007–0.0046). CD39 expression on secreting CD4 Tregs was related to an increased risk of small‐cell lung cancer (SCLC) (OR, 1.0306 [95% CI, 1.0006–1.0616]), mediated by interleukin (IL)‐2 and IL‐6 with mediation proportions of 8.43% (95% CI, 0.00005−0.005) and 5.1% (95% CI, 0.00006–0.003), respectively. CD28 expression on CD39 + CD4 + T cells was positively correlated to lung squamous cell carcinoma (LUSC) risk (OR, 1.0335 [95% CI, 1.009–1.0586]), inversely mediated by IL‐16 (95% CI, −0.01 to −0.0003). Conclusions: These findings reveal the associations between immune cells, inflammatory cytokines, and lung cancer risk, providing insights into cancer diagnosis and treatment.